Regulatory Digest

摘要

At its February meeting the Committee for Proprietary Medicinal Products (CPMP) discussed the procedures and composition of the Therapeutic Advisory Group for Oncology, which is due to be established later this year as part of a pilol scheme. CPMP also agreed on the mandate and rules governing the work of the newly established EMEA/CPMP Working Group with Patients' Associations. Dr Frits Lekkerkerker will chair this working group along with Dr Noel Wathion